Ganesh Raveendran, MD, MBA

• Co-I: A Randomized, Comparative Effectiveness Study of Staged Complete Revascularization with Percutaneous Coronary Intervention to Treat Coronary Artery Disease vs Medical Management Alone in Patients with Symptomatic Aortic Valve Stenosis undergoing Elective Transfemoral Transcatheter Aortic Valve Replacement: The COMPLETE TAVR Study

• Co-I: Randomized Clinical Evaluation of the AccuCinch Ventricular Restoration System in Patients who Present with Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF)

• Co-I: Transcatheter Mitral Valve Replacement with the Medtronic Intrepid TMVR System in patients with severe symptomatic mitral regurgitation; APOLLO Trial

Demetri Yannopoulos, MD
Center for Resuscitation Medicine

• Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock

• Co-I: ECMO-Transplant Outcomes

• Long Term Outcomes and Quality of Life in Patients with Out of Hospital Cardiac Arrest

• Co-I: Physiology of Unloading VA ECMO Trial

• Artificial Intelligence CPR

• Novel Oxygenation

Sergey Gurevich, MD

• Aortic Annulus Dilatation after Variable Pressure Inflation on Multi Slice Computed Tomography for the balloon expandable Transcatheter Aortic Valve Replacement. (ADaPT TAVR)

• Physician X-ray Exposure Study

• Single vs Dual Sensor Fractional Flow Reserve

• Visual Support in the Cardiac Catheterization Laboratory with Augmented Reality Displays

• Change of transaortic gradients post-Surgical Aortic Valve Replacement before and after introduction of Transcatheter Aortic Valve Replacement

• Durability of Transcatheter Aortic Valve Replacement in End Stage Renal Disease

• Impact of Left Atrial Pressure Index on Prognosis in MitraClip

• PK Papyrus Covered Coronary Stent System Humanitarian Use Device

• Gurevitch's current project is Cerebral ECMO